How India's Pharma Industry is Transforming with CRAMS 2.0 and Global R&D Alliances

The Indian pharma sector is experiencing a remarkable shift, growing from the cost-driven outsourcing model into a bustling center of innovation, research, and international alliances.

Amazon Rolls Out Home Diagnostic Services in 6 Major Indian Cities

Amazon India expanded its healthcare services further with the launch of Amazon Diagnostics, an in-home diagnostic testing service to deliver quick, secure, and easy lab testing to the doorsteps of customers.

Anti-Infectives: How New Research is Shaping Infection Control

In an exclusive interaction with India Pharma Outlook, Dr. Pankaj Gupta, Senior Medical Director at Pfizer India, sheds light on the escalating threat of antimicrobial resistance in India’s ICUs. He discusses evo

CII to Hold Hyderabad Meet on Pharma & Chemical Safety

On June 25, 2025, the Confederation of Indian Industry (CII), Telangana will hold a day-long conference, ‘Pillars of Protection – Forging a Safer Future for Pharma and Chemical Manufacturing’ in Hyderabad...

Lilly's Oral Obesity Drug Shows Promise in Phase-III Diabetes Trial

Building on the strong momentum of Mounjaro’s rollout in India, Eli Lilly has reported encouraging clinical trial results for its oral anti-obesity drug, Orforglipron. The new once-daily pill, part of the same GLP-1 drug class as Mounjaro and Zepboun

Lilly Reports Strong Mounjaro Uptake in India, Eyes Expansion

Following its prior report on the clinical success of Mounjaro, Eli Lilly has confirmed a considerable commercial response for the drug in India - the need for effective obesity and diabetes treatment is...

FDA Approves Gilead's Biannual HIV Shot for Long-Term Protection

In a HIV prevention milestone, the US Food and Drug Administration (FDA) has approved Gilead Sciences' lenacapavir, a twice-a-year long-acting injection, for adults and adolescents at risk of HIV infection.

Pharma upgrade drive: IPA-Mysuru backs Revised Schedule M rollout

With the updated Schedule M guidelines representing significant compliance issues for small and medium pharmaceutical units, the Mysuru pharma industry has taken a joint initiative to try and prepare for it...

Eli Lilly Plans Appeal Over UK Refusal to Fund Kisunla Drug

Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug Kisunla, blocking access for patients seeking treatment under the country...

J&J Reports Durable Response in EMD Myeloma With Dual Therapy

Johnson & Johnson reported positive results from a Phase 2 study of the combination of Talvey (talquetamab-tgvs) and Tecvayli (teclistamab-cqyv)—both bispecific antibodies that have been...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.